Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
ASSETS    
Available-for-sale securities, at fair value (amortized cost $8,114,627 and $7,005,013, respectively; allowance for credit losses $6,958 and $14,238, respectively) $ 7,778,734 $ 7,161,703
Mortgage servicing rights, at fair value 2,984,937 2,191,578
Cash and cash equivalents 683,479 1,153,856
Restricted cash 443,026 934,814
Accrued interest receivable 36,018 26,266
Due from counterparties 253,374 168,449
Derivative assets, at fair value 26,438 80,134
Reverse repurchase agreements 1,066,935 134,682
Other assets 193,219 262,823
Total Assets 13,466,160 12,114,305
Liabilities    
Repurchase agreements 8,603,011 7,656,445
Revolving credit facilities 1,118,831 420,761
Term notes payable 398,011 396,776
Convertible senior notes 282,496 424,827
Derivative liabilities, at fair value 34,048 53,658
Due to counterparties 541,709 196,627
Dividends payable 64,504 72,412
Accrued interest payable 94,034 18,382
Commitments and contingencies (see Note 15) 0 0
Other liabilities 145,991 130,464
Total Liabilities 11,282,635 9,370,352
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 26,092,050 and 29,050,000 shares issued and outstanding, respectively ($652,301 and $726,250 liquidation preference, respectively) 630,999 702,550
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 86,428,845 and 85,977,831 shares issued and outstanding, respectively 864 860
Additional paid-in capital 5,645,998 5,627,758
Accumulated other comprehensive (loss) income (278,711) 186,346
Cumulative earnings 1,453,371 1,212,983
Cumulative distributions to stockholders (5,268,996) (4,986,544)
Total Stockholders’ Equity 2,183,525 2,743,953
Total Liabilities and Stockholders’ Equity $ 13,466,160 $ 12,114,305